257 related articles for article (PubMed ID: 6546890)
21. End results of treating children with localized non-Hodgkin's lymphomas with a combined modality approach of lessened intensity.
Murphy SB; Hustu HO; Rivera G; Berard CW
J Clin Oncol; 1983 May; 1(5):326-30. PubMed ID: 6668503
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphomas in children. II. Treatment.
White L; Siegel SE; Quah TC
Crit Rev Oncol Hematol; 1992 Jul; 13(1):73-89. PubMed ID: 1449620
[TBL] [Abstract][Full Text] [Related]
23. Primary peripheral nodal lymphoma in children.
Wollner N; Exelby P; Lindsley KL; Lieberman P; Filippa D; Heller G
Cancer; 1993 Jun; 71(11):3670-9. PubMed ID: 8490916
[TBL] [Abstract][Full Text] [Related]
24. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol.
Todeschini G; Tecchio C; Degani D; Meneghini V; Marradi P; Balter R; Zanotti R; Ricetti M; Franchini M; Perona G
Ann Oncol; 1997; 8 Suppl 1():77-81. PubMed ID: 9187436
[TBL] [Abstract][Full Text] [Related]
25. Additional chemotherapy agents improve treatment outcome for children and adults with advanced B-cell lymphomas.
Adde M; Shad A; Venzon D; Arndt C; Gootenberg J; Neely J; Nieder M; Owen W; Seibel N; Wilson W; Horak ID; Magrath I
Semin Oncol; 1998 Apr; 25(2 Suppl 4):33-9; discussion 45-8. PubMed ID: 9578060
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
27. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
28. Poor-risk non-lymphoblastic lymphoma of childhood: results of an intensive pilot study.
Finlay JL; Trigg ME; Link MP; Frierdich S
Med Pediatr Oncol; 1989; 17(1):29-38. PubMed ID: 2913472
[TBL] [Abstract][Full Text] [Related]
29. Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.
Sullivan MP; Ramirez I
J Clin Oncol; 1985 May; 3(5):627-36. PubMed ID: 3839010
[TBL] [Abstract][Full Text] [Related]
30. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's).
Wilson JF; Kjeldsberg CR; Sposto R; Jenkin RD; Chilcote RR; Coccia P; Exelby RR; Kersey J; Meadows A; Siegel S
Hum Pathol; 1987 Oct; 18(10):1008-14. PubMed ID: 3653876
[TBL] [Abstract][Full Text] [Related]
31. [Maxillofacial location of Burkitt's lymphoma in children treated at the University Hospital Center in Bamako, Mali: a 24-case series].
Togo B; Keita M; Medefo D; Traore F; Sidibe T
Med Trop (Mars); 2008 Dec; 68(6):600-2. PubMed ID: 19639827
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
33. CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Moleti ML; Testi AM; Giona F; Malandruccolo L; Pescarmona E; Martino P; Paoloni F; Barberi W; Palumbo G; Mandelli F; Foa R
Leuk Lymphoma; 2007 Mar; 48(3):551-9. PubMed ID: 17454598
[TBL] [Abstract][Full Text] [Related]
34. Management of pediatric non-Hodgkin's lymphoma.
Blay JY; Louis D; Bouffet E; Thiesse P; Biron P; Favrot MC; Brunat-Mentigny M; Philip T
Blood Rev; 1991 Jun; 5(2):90-7. PubMed ID: 1912759
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA
Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967
[TBL] [Abstract][Full Text] [Related]
36. Combined chemotherapy in 76 children with non-Hodgkin's lymphoma excluding Burkitt's lymphoma.
Büyükpamukçu M; Sarialioğlu F; Akyüz C; Cevik N
Br J Cancer; 1987 Nov; 56(5):625-8. PubMed ID: 3426926
[TBL] [Abstract][Full Text] [Related]
37. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
[TBL] [Abstract][Full Text] [Related]
38. Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
Murphy SB; Bowman WP; Hustu HO; Berard CW
IARC Sci Publ; 1985; (60):405-18. PubMed ID: 3905592
[TBL] [Abstract][Full Text] [Related]
39. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
[TBL] [Abstract][Full Text] [Related]
40. Management of high-grade lymphomas.
Magrath IT
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):40-8. PubMed ID: 9830632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
